創百簡介 About Chambio
創百股份有限公司是結合一群有經驗的專業人士所組成的生命科學公司，成立於2007年， 是台灣重要的保健食品原料商之一，並於2018年在上海設立分公司「上海創百生物科技有限公司」，為提供客戶更完整的服務，2020年成立台灣分公司「創百生物科技股份有限公司」，提供客戶高品質、高性價比的各種機能性保健品牌原料，以獨有「倍乘營養科學」為本的整體解決方案技術服務( Total Solution Services ) ：原料供應、產品概念、配方設計、技術諮詢及保健食品代工生產，包括預混料、半成品及成品等，為客戶開創獨特、優質及有市場競爭優勢的產品。
我們專注於品牌原料及倍乘配方的經營，與歐、美、日、韓等多家國際知名功能性營養原料公司合作，獨家經銷的品牌超過30項。 為確保產品品質與安全，創百除取得 ISO-9001、ISO-22000 及 HACCP 驗證與設置自有品研實驗室及品管專業團隊以外，並密切與有公信力的第三方檢驗單位合作進行原料到產品的品質管控，以保障客戶權益。
我們的客戶不僅含括台灣的知名大藥廠、食品廠、品牌商及通路商，也包括國外多家跨國企業，我們的產品及服務品質深獲客戶肯定。
同時為增加客戶對我們的瞭解與信任，創百也已取得國際權威徵信機構「鄧白氏 The Dun & Bradstreet」的企業認證。
- 台灣總公司：創百股份有限公司
- 台灣分公司：創百生物科技股份有限公司
- 上海分公司：上海創百生物科技有限公司
D-U-N-S® Number (鄧白氏環球編碼):656268245, D&B Rating: 3A2
創百品管及研發實驗室
創百的品牌價值是建立在大量科學證據及安全數據上！
期刊、文獻、專利、國際認證、品質文件、第三方公正單位化驗報告等俱全。
經營理念 Mission & Vision
『安全、品質、功效、服務』是創百秉持的經營理念，並以誠信為本。為了實現此核心價值，公司多年來不間斷投入資源提升技術與能力，為客戶提供優質產品與技術服務，協助客戶行銷和開拓市場，創造附加價值，共創雙贏，期許創百提供的產品與服務能臻於完美，止於至善，達成『創百分客戶滿意、創百世人類幸福』的願景。
創百用心、客戶放心，讓客戶安心與滿意是我們的承諾。
創新導向 Innovation Driven
專利申請與取得：
| Patent title | Granted | Pending | |
| Taiwan | 後生元提取物的製備方法以及由該方法所得到的產物及其用於抑制生物膜形成與促進腸道健康之用途。 A method for preparing postbiotic extract, and its products obtained therefrom for inhibiting biofilm formation and promoting intestinal health. | TW I733446 | |
| 後生元提取物用於預防和/或治療關節炎與關節退化的用途。 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. | TW I739424 | ||
| 後生元提取物用於促進皮膚再生與抗老化的用途。 The use of postbiotic extract for promoting skin regeneration and anti-aging. | TW I748448 | ||
| 具有核殼結構的益生菌顆粒。 Probiotic particles with nuclear-shell structure. | TW M602905U | ||
| 使用熱致死的乳酸菌菌株來治療和/或預防微粒物質-誘發的肺損傷。 The use of heat-killed Lactobacillus strains for treating and/or preventing particulate matter-induced lung injury. | TW I802009 | ||
| 使用一包含有植物乳桿菌 CB102 分離株與燕窩酸的組合來改善皮膚病況。 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid for improving skin conditions. | TW I808582 | ||
| 益生菌與後生元的組合在改善 SARS-CoV-2 感染相關的病況上的用途。 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. | TW I858748 | ||
| 使用寡糖配方來生產乳酸菌脂壁酸的方法。 Method for producing lipoteichoic acid from lactic acid bacteria using an oligosaccharide formula | 113102293 | ||
| 具有穩定包覆活性成分能力之複合結構保健品。 A composite structural health supplement with the ability for stable encapsulation of active ingredients. | TW M655351 | ||
| 具有酵素活性物質之微粒結構保健品。 Health Supplement Containing Microparticle Structures with Enzymatic Activity. | TW M660619 | ||
| 植物乳桿菌 CB102 的後生元萃取物及其製備方法與降低血中尿酸用途。 The Preparation Method of Lactobacillus plantarum-derived Postbiotics CB-102 and Its Application in Reducing Blood Uric Acid Levels. | 113129230 | ||
| China | 後生元提取物的製法以及該方法得到的產物及其抑制生物膜形成與促進腸道健康的用途。 The method of preparing postbiotic extract, the product obtained by the method, and its use for inhibiting biofilm formation and promoting intestinal health. | CN 113925158B | |
| 後生元提取物用於預防和/或治療關節炎與關節退化的用途。 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. | CN 113925885B | ||
| 後生元提取物用於促進皮膚再生與抗老化的用途。 The use of postbiotic extract for promoting skin regeneration and anti-aging. | CN 113925884B | ||
| 具有核殼結構的益生菌顆粒及益生菌軟膠囊。 Probiotic particles with nuclear-shell structure and probiotic soft capsules. | CN 213549547U | ||
| 熱致死的乳酸菌菌株作為製備治療和/或預防微粒物質-誘發的肺損傷的醫藥品的用途。 The use of heat-killed Lactobacillus strains as a pharmaceutical preparation for the treatment and/or prevention of particulate matter-induced lung injury. | 202111291686.0 | ||
| 包含植物乳桿菌 CB102 與燕窩酸的組合在製備用來改善皮膚病況的組合物中的用途。 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid in the preparation of a composition for improving skin conditions. | 202211396626.X | ||
| 益生菌與後生元的組合在改善 SARS-CoV-2 感染相關的病況上的用途。 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. | 202310870474.0 | ||
| 植物乳桿菌 CB102 的後生元萃取物及其製備方法與降低血中尿酸用途。 The Preparation Method of Lactobacillus plantarum-derived Postbiotics CB-102 and Its Application in Reducing Blood Uric Acid Levels. | 202411226243.7 | ||
| USA | POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF. | US 11541085 B2 | |
| METHOD FOR ALLEVIATING ARTHRITIS WITH POSTBIOTIC EXTRACT. | US 11517596 B2 | ||
| METHOD FOR IMPROVING SKIN CONDITION WITH POSTBIOTIC EXTRACT. | US 11517597 B2 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF. "splitting case" (inhibiting biofilm formation) | US 11,931,388 B2 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF. "Splitting case" (promoting intestinal health) | US 11,925,668 B2 | ||
| METHOD FOR PREVENTING OR ALLEVIATING PARTICULATE MATTER-INDUCED LUNG INJURY. | US 12,090,182B2 | ||
| METHOD OF USING A COMBINATION OF POSTBIOTICS AND PROBIOTICS FOR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION-ASSOCIATED DISORDERS. | 18/499450 |
學術發表：
| Year | Papers title | Journal/Exhibition name |
| 2023 | 後生元協同益生菌減輕由 PM2.5 引起的肺損傷及過敏。 Synergistic effect of probiotic and postbiotic on attenuation of PM2.5-induced lung damage and allergic response. | J Food Sci. 2023;88(1):513-522. doi:10.1111/1750-3841.16398 |
| 葉黃素、玉米黃素、綠薄荷萃取物降低網膜及角膜細胞氧化壓力具有加成效果。 The synergistic effects of lutein, zeaxanthin, and spearmint extract on the antioxidant activity in APRE-19 and HCE-T cells. | FAOPS Congress | |
| 久司酵素增強版透過纖維與體內油脂結合與促進排出來改善腸道健康。 BraziZyme® PLUS improves gastrointestinal health through its fiber-mediated binding and excretion of intracellular lipids. | 2023 台灣乳酸菌協會研討會。 2023 Taiwan Association for Lactic Acid Bacteria Conference. | |
| 2024 | 黑豆種皮萃取物及其複方具有保護角膜細胞之效果 Protective Effect of Black Bean Hull Extract and Its Formula on Human Corneal Epithelial Cells. | 2024台灣保健食品學會年會暨國際學術研討會 2024 Taiwan Health Food Society Annual Conference and International Academic Symposium |
| ProbioGABA® 倍乘配方對於睡眠品質與情緒穩定之改善效果 ProbioGABA®, the Synscience Inside Formula, improves Sleep Quality and Emotional Well-being. | 2024台灣營養學會年會暨學術研討會 2024 Nutrition Society of Taiwan Annual Conference and Academic Symposium |
獲獎殊榮 Awards
| Year | Name | Award | Area |
| 2023 | 2023 營養智造-微生態先鋒獎_後生元乳酸菌三次方增肌複方。 2022 New Nutrition Business-Microecology Pioneer Award-Postbiotics Tri-Cubic Muscle Building Complex with Probiotic. | 新營養大會暨營養盒頒獎。 New Nutrition Business-Nutrition Box Award. | China |
| 益生聯®、益生捷® 和益生妍® 新系統用於抑制壞菌、促進腸道健康、預防和治療關節炎以及促進皮膚再生與抗老化。 A new system of Probiogenics®, ProbioFlex® and ProbioHya® inhibits harmful bacteria, improves gut health, prevents and treats arthritis, promotes skin regeneration and anti-aging. | 日本東京天才發明獎。 World Genius Convention & Education Expo - Gold Award. | Japan | |
| 瑞士日內瓦發明獎_特別獎。 Geneva International Exhibition of Inventions - Special Award. | Switzerland | ||
| 瑞士日內瓦發明金獎。 Geneva International Exhibition of Inventions - Gold Award. | Switzerland | ||
| 一種專利微活化的 / probioAid® / PROBIOPTIMA® LM-1004 後生元 ( 類生元® ) 技術。 A patented technology for micro-activating probioAid® / PROBIOPTIMA® LM1004 postbiotic. | iSEE 創新技術 TOP50 榜。 iSEE Award TOP50. | China | |
| 一種生產活性後生元 L-137 ( 類生元® ) 的熱封存技術。 A heat-treated technology for manufacturing bioavailable L-137 postbiotics. | iSEE 創新技術 TOP50 榜。 iSEE Award TOP50. | China | |
| 專利微活化後生元 probioAid® / PROBIOPTIMA® LM-1004 ( 類生元® )。 A patented technology for micro-activating probioAid® / PROBIOPTIMA® LM1004 postbiotic. | 天然新勢力_源創配料獎。 Natural New Force Awards. | China | |
| 2022 | PROBIOPTIMA® / probioAid® LM-1004 | 日本天才發明金獎_體重管理。 World Genius Convention & Education Expo - Gold Award in Weight Management. | Japan |
| 營養智造-解決方案開拓者獎。 2022 New Nutrition Business-Solution Pioneer Award. | 新營養大會暨營養盒頒獎。 New Nutrition Business-Nutrition Box Award. | China | |
| 2021 | 營養智造-新植物力量獎。 2021 New Nutrition Business-New Plant Power Award. | 新營養大會暨營養盒頒獎。 New Nutrition Business-Nutrition Box Award. | China |
| 2020 | 營養智造-應用之星獎。 2020 New Plant Power Award-Application Star Award. | 新營養大會暨營養盒頒獎。 New Nutrition Business-Nutrition Box Award. | China |
